CD68 and glioblastoma: Wu et al. reported that MerTK/CD68+ macrophages increase in recurrent tumors, and suggested that MerTK inhibition combined with fractionated external beam radiotherapy (XRT) has a therapeutic effect in a subset of GBM [105].